CoChat

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel

The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Alterations in glucose and lipid metabolism, lactic acidemia, bone disorders, and abnormal body fat distribution have been recognized recently as frequent complications associated with HIV-1 infection and potent antiretroviral therapy, but limited data are available regarding the appropriate management of these disorders. These recommendations were developed to guide physicians actively involved in HIV care in the management of metabolic complications that occur primarily within the context of potent antiretroviral therapy. PARTICIPANTS: A 12-member panel representing international expertise in HIV-1 patient care, antiretroviral therapy, and endocrine and metabolic disorders was selected in the spring of 2000 by the International AIDS Society-USA, a not-for-profit physician education organization. Panel members met in closed meetings beginning in May 2000. All work was funded by the International AIDS Society-USA; the panel members are not compensated for their participation. EVIDENCE: The panel reviewed published results of clinical, epidemiologic, and basic science studies and data and abstracts presented at research conferences, primarily from 1997 to 2002. The panel also considered studies of the pathophysiology and treatment of similar metabolic abnormalities in noninfected persons. Emphasis was placed on results from prospective, randomized, controlled clinical trials when available. PROCESS: For each metabolic complication, 1 or more member(s) reviewed and presented all available evidence to the panel, and then wrote a summary of the evidence and preliminary recommendations. Final recommendations were determined by full group consensus. The summaries were combined into a single working document and all panel members edited and approved all subsequent drafts. CONCLUSIONS: Carefully controlled studies to determine the incidence, etiology, risk factors, and most appropriate treatments for metabolic complications in HIV-1 infection are urgently needed. In the absence of these data, and to prevent acute illness and mitigate long-term risks, the panel recommends routine assessment and monitoring of glucose and lipid levels and assessment and monitoring of lactic acidemia and bone abnormalities if clinical signs or symptoms are detected. With the exception of body fat distribution abnormalities, specific treatments for these complications are also recommended. Successful long-term antiretroviral therapy will require diligent monitoring and preemptive treatment of metabolic complications to optimize the risk-benefit ratio of antiretroviral therapies.

Overview

Integrity signals

Registry

Crossref · 10.1097/00126334-200211010-00001

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 177 references

Research works printed but not linked: 21

  1. Mulligan, 2000, J Acquir Immune Defic Syndr, 23, 35, 10.1097/00126334-200001010-00005 · doi:10.1097/00126334-200001010-00005 · Paper page
  2. Walli, 2001, Eur J Med Res, 6, 413
  3. 2000, Diabetes Care, 23, S32
  4. Gelato, 2002, J Invest Med, 50, 177A
  5. Zangerle, 1994, J Acquir Immune Defic Syndr, 7, 1149
  6. Dong, 1999, J Acquir Immune Defic Syndr, 21, 107
  7. Ruiz, 2001, J Acquir Immune Defic Syndr, 27, 229, 10.1097/00126334-200107010-00003 · doi:10.1097/00126334-200107010-00003 · Paper page
  8. Saag, 2002, Topics HIV Med, 10, 47
  9. de Luis, 1999, Med Clin Barc, 113, 716
  10. Busetto, 1992, Int J Obes Relat Metab Disord, 16, 731
  11. Rigsby, 1992, Med Sci Sports Exerc, 24, 6
  12. Rebuffe-Scrive, 1991, Int J Obes, 15, 791
  13. Marin, 1992, Int J Obes Relat Metab Disord, 16, 991
  14. Marin, 1992, Eur J Med, 1, 329
  15. Lovejoy, 1995, Int J Obes Relat Metab Disord, 19, 614
  16. Calmy, 2001, Antivir Ther, 6, 32
  17. Fortgang, 1995, Am J Gastroenterol, 90, 1433
  18. White, 2000, Antivir Ther, 5, 72
  19. Chen, 1993, Diabete Metab, 19, 348
  20. Goorney, 1990, Genitourin Med, 66, 451
  21. Gerster, 1991, J Rheumato, 18, 300

Cited by

See all 380

Metadata

Authors
Schambelan, M., Benson, C. A., Carr, A., Currier, J. S., Dubé, M. P., Gerber, J. G., Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Mulligan, K., Powderly, W. G., & Saag, M. S.
Affiliations
  • San Francisco General Hospital (US)
  • San Francisco VA Medical Center (US)
  • St Vincent's Hospital Sydney (AU)
  • Washington University in St. Louis (US)
  • Harvard University (US)
  • Columbia University (US)
  • University of Alabama at Birmingham (US)
Corresponding author
  • Schambelan, Morris
  • Grinspoon, Steven K.
  • Saag, Michael S.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2002-11
Volume
31
Issue
3
Pages
257-275
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2063244503
Cited by
379
References
177
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 10 · 2017: 8 · 2016: 7 · 2015: 6 · 2014: 14 · 2013: 12 · 2012: 15
FWCI
45.04
Type
journal article
Language
en
Open access
closed
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
HIV-1 infection, antiretroviral therapy, metabolic complications, glucose metabolism, lipid metabolism, lactic acidosis, bone disease, body fat distribution, metabolic monitoring, treatment guidelines
MeSH terms
Adipose Tissue, Bone Diseases, Metabolic, Glucose, Homeostasis, Humans, Insulin Resistance, Lipoproteins, Metabolic Diseases, HIV-1, HIV Infections, Lactic Acid, Anti-HIV Agents, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. https://app.cochat.ai/papers/10.1097/00126334-200211010-00001
The paper
Schambelan, M., Benson, C. A., Carr, A., Currier, J. S., Dubé, M. P., Gerber, J. G., Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Mulligan, K., Powderly, W. G., & Saag, M. S. (2002). Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00126334-200211010-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.